Table: Towa Pharmaceutical - 9-MTH group results

TOWA PHARMACEUTICAL

13/02/2023 06:00

Feb 13 (Reuters)- 
             Towa Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2022        Dec 31, 2021     Mar 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              140.41              125.61           212.50    
                   (+11.8 pct)         (+9.0 pct)       (+28.3 pct) 
  Operating            5.35               16.99             7.90    
                   (-68.5 pct)         (+14.9 pct)      (-58.9 pct) 
  Recurring            4.64               21.06             7.50    
                   (-78.0 pct)         (+61.4 pct)      (-67.0 pct) 
  Net                  1.98               15.00             3.70    
                   (-86.8 pct)         (+58.8 pct)      (-76.8 pct) 
  EPS               40.32 yen          304.80 yen        75.17 yen  
  EPS Diluted                          298.05 yen                   
  Ann Div                               60.00 yen        60.00 yen  
  -Q2 div           30.00 yen           27.00 yen                   
  -Q4 div                               33.00 yen        30.00 yen  
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T